H.R. 7384
IntroducedCreating Hope Reauthorization Act of 2024
Plain-language analysis
Not yet analyzed.
A plain-language breakdown — including any hidden or off-intent provisions and whether the bill was fast-tracked — is generated separately and reviewed before publishing. It will appear here once ready. Until then, the verbatim text below and the official source are the record.
Full text of the bill
Official source on Congress.gov ↗[Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [H.R. 7384 Introduced in House (IH)]
<DOC>
118th CONGRESS 2d Session H. R. 7384
To amend the Federal Food, Drug, and Cosmetic Act to extend the authority of the Secretary of Health and Human Services to issue priority review vouchers to encourage treatments for rare pediatric diseases.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
February 15, 2024
Mr. McCaul (for himself, Ms. Eshoo, Mr. Bilirakis, Ms. Barragan, Mrs. Trahan, and Mr. Burgess) introduced the following bill; which was referred to the Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To amend the Federal Food, Drug, and Cosmetic Act to extend the authority of the Secretary of Health and Human Services to issue priority review vouchers to encourage treatments for rare pediatric diseases.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Creating Hope Reauthorization Act of 2024''.
SEC. 2. EXTENSION OF AUTHORITY TO ISSUE PRIORITY REVIEW VOUCHERS TO ENCOURAGE TREATMENTS FOR RARE PEDIATRIC DISEASES.
Section 529(b)(5) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360ff(b)(5)) is amended--
(1) by striking ``September 30, 2024'' each place it appears and inserting ``September 30, 2028''; and
(2) in subparagraph (B), by striking ``September 30, 2026'' and inserting ``September 30, 2030''. <all>